Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanodrop vs Systane Balance for Dry Eye
NCT04111965Phase 2Completed
- Sponsor
- Laboratorios Sophia
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PRO-176 in dry eye syndrome (DED) (2 arms), sponsored by Laboratorios Sophia. Primary endpoints: Ocular Surface Disease Index at Day 29 and Percentage of Unexpected Adverse Events Related to Research Product at Day 29. Started Dec 2020; status: completed.
02
Drugs
PRO-176
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04111965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04111965.